ConductScience.org, home

Gene · 23521

NIH grants2,185

NIH grants whose papers are about the gene, through NIH's grant-paper links.

1,061 to 1,080 of 2,185

Download this page as JSON
GrantTitleRPL13A papersNewest fiscal year
R01GM115476Mechanisms and Regulation of Programmed Translational Readthrough12019
R01GM115622REAL-TIME QUANTITATIVE IMAGING OF INTRACELLULAR BIOTHIOL DYNAMICS12019
R01GM117333High Resolution Analysis of Transcription-Splicing Coupling12019
R01HD079951Preventive Approach to Congenital Heart Block with Hydroxychloroquine (PATCH)12019
R01HL060942Leptin deficiency changes mast cell pro-inflammatory activity12019
R01HL097111Receptor-regulated Ca2+ entry pathways in smooth muscle12019
R01HL125850Neuroimmune Molecules in Scleroderma Lung Fibrosis12019
R01HL128241Prostaglandin D2: A Key Mediator of Aspirin-Exacerbated Respiratory Disease12019
R01HL128485miRNA Regulation of the Mitochondrial Genome12019
R01HL130233Atherogenic roles of complement system12019
R01HL131460Caspase-1 activation mediates chronic kidney disease-accelerated atherosclerosis12019
R01HL132058Identification of a novel modulator of Pulmonary Artery Hypertension12019
R01MH105442Mechanisms of circuit failure and treatments in patient-derived neurons in autism12019
R01NS050375The genetic basis of Dandy-Walker and other mid-hindbrain malformations12019
R01NS063964TDP-43, RNA Metabolism, and ALS/FTD Pathology12019
R01NS073873Identification of ALS associated genes using whole genome sequencing12019
R01NS092652Brainstem regulation of sleep12019
R01NS095280Drug-mediated enhancement of myelination12019
R03CA230819Elucidating Novel Mechanisms Underlying Prostate Cancer Development12019
R15ES030140Interactions of Engineered Nanomaterials with the Cell Plasma Membrane12019

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/23521/grants?page=54